Who Owns ENVB?

Enveric Biosciences, Inc. — Institutional Ownership & 13F Holdings

$4.08

+0.13 (+3.29%)

Market Cap

$1.2M

Shares Outstanding

597,012

Institutional Holders

15

Total Inst. Value

$287K

% of Float Held

49.1%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AdvisorShares Investments LLC$118K90,324
2UBS Group AG$59K42,760
3GEODE CAPITAL MANAGEMENT, LLC$36K26,558
4Virtu Financial LLC$36K25,622
5CITADEL ADVISORS LLC$28K20,060
6FMR LLC$4K3,426
7Tower Research Capital LLC (TRC)$3K2,372
8SBI Securities Co., Ltd.$1K725
9BlackRock, Inc.$835601
10Headlands Technologies LLC$153110

Related Stocks

Frequently Asked Questions

How many institutional investors hold ENVB?

As of Q1 2025, 15 institutional investors report holding ENVB (Enveric Biosciences, Inc.) in their 13F filings.

What percentage of Enveric Biosciences, Inc. is owned by institutions?

Institutional investors hold approximately 49.1% of Enveric Biosciences, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most ENVB?

The largest institutional holder of ENVB is AdvisorShares Investments LLC with $118K in shares.

Are institutions buying or selling ENVB?

This quarter, 15 institutions opened new positions in ENVB and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.